The effect we demonstrated here (taken as continuous or categorical variables) for CRP, Neu, Alb, CEA, and CYFRA 21-1 in relation to PFS and/or OS only highlights this issue in our group of patients treated with first-line chemotherapy for advanced NSCLC. This evidence concerns the gene ALB and non-small cell lung carcinoma.